Sedation strategy and ICU delirium: a multicentre, population-based propensity score-matched cohort study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
20 07 2021
Historique:
entrez: 21 7 2021
pubmed: 22 7 2021
medline: 5 8 2021
Statut: epublish

Résumé

We examined the relationship between dominant sedation strategy, risk of delirium and patient-centred outcomes in adults admitted to intensive care units (ICUs). Retrospective propensity-matched cohort study. Mechanically ventilated adults (≥ 18 years) admitted to four Canadian hospital medical/surgical ICUs from 2014 to 2016 in Calgary, Alberta, Canada. 2837 mechanically ventilated adults (≥ 18 years) requiring admission to a medical/surgical ICU were evaluated for the relationship between sedation strategy and delirium. None. The primary exposure was dominant sedation strategy, defined as the sedative infusion, including midazolam, propofol or fentanyl, with the longest duration before the first delirium assessment. The primary outcome was 'ever delirium' identified using the Intensive Care Delirium Screening Checklist. Secondary outcomes included mortality, length of stay (LOS), ventilation duration and days with delirium. The cohort was analysed in two propensity score (patient characteristics and therapies received) matched cohorts (propofol vs fentanyl and propofol vs midazolam). 2837 patients (60.7% male; median age 57 years (IQR 43-68)) were considered for propensity matching. In propensity score-matched cohorts(propofol vs midazolam, n=712; propofol vs fentanyl, n=1732), the odds of delirium were significantly higher with midazolam (OR 1.46 (95% CI 1.06 to 2.00)) and fentanyl (OR 1.22 (95% CI 1.00 to 1.48)) compared with propofol dominant sedation strategies. Dominant sedation strategy with midazolam and fentanyl were associated with a longer duration of ventilation compared with propofol. Fentanyl was also associated with increased ICU mortality (OR 1.50, 95% CI 1.07 to 2.12)) ICU and hospital LOS compared with a propofol dominant sedation strategy. We identified a novel association between fentanyl dominant sedation strategies and an increased risk of delirium, a composite outcome of delirium or death, duration of mechanical ventilation, ICU LOS and hospital LOS. Midazolam dominant sedation strategies were associated with increased delirium risk and mechanical ventilation duration.

Identifiants

pubmed: 34285003
pii: bmjopen-2020-045087
doi: 10.1136/bmjopen-2020-045087
pmc: PMC8292822
doi:

Substances chimiques

Hypnotics and Sedatives 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e045087

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Anesthesiology. 2001 Aug;95(2):286-98
pubmed: 11506097
Crit Care Med. 2013 Jan;41(1):263-306
pubmed: 23269131
Crit Care. 2019 May 23;23(1):186
pubmed: 31122276
Crit Care Med. 1998 Apr;26(4):676-84
pubmed: 9559604
JAMA. 2004 Apr 14;291(14):1753-62
pubmed: 15082703
Intensive Care Med. 2001 Aug;27(8):1297-304
pubmed: 11511942
Crit Care Med. 1997 Jan;25(1):33-40
pubmed: 8989173
JAMA. 2009 Feb 4;301(5):489-99
pubmed: 19188334
PLoS Med. 2009 Jun 23;6(6):e1000098
pubmed: 19554085
Am J Respir Crit Care Med. 2002 Nov 15;166(10):1338-44
pubmed: 12421743
Crit Care. 2005 Aug;9(4):R375-81
pubmed: 16137350
JAMA. 2005 Aug 17;294(7):813-8
pubmed: 16106006
Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
Clin Pharmacol Ther. 1988 Mar;43(3):263-9
pubmed: 3345618
Intensive Care Med. 2008 Nov;34(11):1969-79
pubmed: 18575838
Crit Care Med. 1996 Jun;24(6):932-9
pubmed: 8681594
JAMA. 2001 Dec 5;286(21):2703-10
pubmed: 11730446
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
JAMA Intern Med. 2018 Oct 1;178(10):1390-1399
pubmed: 30128550
Crit Care Med. 2015 Jan;43(1):40-7
pubmed: 25251759
J Trauma. 2008 Jul;65(1):34-41
pubmed: 18580517
J Neuroimmunol. 1998 Mar 15;83(1-2):4-18
pubmed: 9610668
Anesthesiology. 2006 Jan;104(1):21-6
pubmed: 16394685
Intensive Care Med. 2001 May;27(5):859-64
pubmed: 11430542
Crit Care Med. 1990 Nov;18(11):1282-6
pubmed: 2225900
J Neuroimmune Pharmacol. 2006 Mar;1(1):77-89
pubmed: 18040793
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1383-94
pubmed: 24720509
Crit Care Med. 2005 Mar;33(3):574-9
pubmed: 15753749
Lancet. 1989 Sep 23;2(8665):704-9
pubmed: 2570958
Am J Respir Crit Care Med. 2012 Oct 15;186(8):724-31
pubmed: 22859526
J Crit Care. 2018 Oct;47:295-301
pubmed: 30099330
Br J Clin Pharmacol. 2004 Feb;57(2):135-45
pubmed: 14748812
Lancet. 2008 Jan 12;371(9607):126-34
pubmed: 18191684
Neurochem Res. 1996 Nov;21(11):1375-86
pubmed: 8947928
Chest. 2009 Sep;136(3):759-764
pubmed: 19736189

Auteurs

Colin Casault (C)

Department of Critical Care Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada casaultc@gmail.com.

Andrea Soo (A)

Department of Critical Care Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Chel Hee Lee (CH)

Department of Critical Care, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Philippe Couillard (P)

Department of Critical Care Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Daniel Niven (D)

Department of Critical Care Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Tom Stelfox (T)

Department of Critical Care, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Kirsten Fiest (K)

Department of Critical Care Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH